feed,title,long_url,short_url
Benzinga,FDA Backs Immutep's Eftilagimod Registrational Trial In Metastatic Breast Cancer,https://benzinga.com/general/biotech/22/03/26075472/fda-backs-immuteps-eftilagimod-registrational-trial-in-metastatic-breast-cancer,https://bit.ly/3tPInXP
